Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days.
Read storyNeuroHIV occurs when HIV infection affects the function and structural integrity of the brain and, to some extent, the spinal cord and peripheral nervous system. New research has identified a brain protein driving this damage, pointing toward a possible treatment.
A new clinical trial is recruiting people diagnosed with anorexia nervosa as researchers hope to discover if fecal microbiota transplant (FMT) capsules could help better manage this eating disorder.
This technology enables the direct rescue of segmented negative-sense RNA viruses from complementary DNA in monkey kidney Vero cells, facilitating safer and more efficient live-attenuated vaccine production.
Three simple cleaning methods reduced bacterial levels on used single-use medical devices, according to a study. The findings could prove useful as a last-resort measure during severe shortages of medical supplies in a crisis or war.
Rainwater tanks are a popular way for Australians to save water, but new research has found they can also harbour potentially harmful bacteria and metals that could pose health concerns.
The WHO 4th Global Action Plan for Poliovirus Containment (GAPIV) mandates poliovirus-essential facilities (PEFs) to validate on-site decontamination protocols for non-enveloped poliovirus, a pathogen resistant to many routine disinfectants. A study assessed two commercial biosecurity disinfectants.
Researchers have developed a new screening program for congenital cytomegalovirus, the most common infection passed from mothers to babies during pregnancy. While many babies with congenital cytomegalovirus have no obvious symptoms, some can develop hearing loss, developmental delays or other medical complications as they grow.
A new research project will investigate how Strep B bacteria attach to the vaginal tract and the mechanisms they use to stay there. In newborns, Strep B infections can kill and the study will look at how Streptococcus agalactiae comes to colonize the birth canal in the first place, which may lead to improved preventative measures.
Led by the University of Oxford in partnership with the WHO and an international consortium the three-year PANDAI project will develop and deploy advanced AI models to transform the detection, assessment, prediction and response to global disease threats.
This study is the first to demonstrate the potential of combining Electronic Genome Mapping (EGM) with CRISPR/Cas9 to both characterize CRISPR/Cas9 activity and enhance the capabilities of genome mapping.
Scientists have used bacterial genome sequencing to understand why the meningococcal disease outbreak in Kent earlier this year was so severe. The outbreak bacteria had picked up genetic material from other, less harmful bacteria found naturally in the throats of many healthy people.
PACE and the UK Health Security Agency have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.
A new prospective study found that children at high genetic risk of type 1 diabetes whose gut microbiome development plateaued early had about three times the risk of developing the disease compared with children whose microbiomes continued to mature.
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy for therapeutic intervention.
A new study reveals that combining an immunotherapy with the traditional Bacille Calmette-Guérin (BCG) vaccine drastically lowers the risk of TB relapse in preclinical models.
Researchers have discovered that gut bacteria and the compounds they produce trigger biological processes that the human body on its own can only activate with difficulty. They help suppress inflammation and may also have beneficial effects on fatty liver disease.
Researchers reveal the molecular mechanism by which Plasmodium falciparum responds to stress by increasing the production of the sexual forms required for transmission.
A new study sheds fresh light on the long and complex history of the plague by analysing the DNA of the bacterium. Researchers reconstructed 26 genomes of Yersinia pestis from archaeological sites in Estonia, Russia, England, the Netherlands, and Switzerland.
Researchers find that the phosphoglycerate kinase 1 (PGK1) uses its non-canonical protein kinase activity to disrupt a host chaperone required by multiple viruses, suggesting a potential strategy for host-directed antiviral therapy.
Researchers have found that, even before vaccination, some people’s innate immune systems are more reactive than others, showing a heightened response to interferons. The stronger this response, the more likely individuals are to experience these transient symptoms.
A chirality-engineered nanozyme restores gut microbiota and host metabolism to prevent doxorubicin-induced cardiotoxicity without compromising anticancer efficacy.
The Global Virus Network (GVN) is closely monitoring detections of highly pathogenic avian influenza A (H5N1), commonly known as bird flu, in several mammal species in Australia as the virus continues to spread among birds and mammals worldwide.